| 1 |
33040554 | Rectal diclofenac for prevention of post-endoscopic retrograde cholangiography pancreatitis. | 2021 Feb |
3 |
| 2 |
32292447 | Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis. | 2020 Mar-Apr |
2 |
| 3 |
32624663 | Rectal versus intramuscular diclofenac in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: experience of a Greek tertiary referral center. | 2020 Jul-Aug |
1 |
| 4 |
31612188 | Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study. | 2019 Sep-Oct |
4 |
| 5 |
27849643 | Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. | 2017 Mar |
2 |
| 6 |
25438071 | Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac. | 2015 Mar |
1 |